We've found
184,457
clinical trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
PSD502 in Subjects With Premature Ejaculation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
PSD502 in Subjects With Premature Ejaculation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib With or Without Olaparib in Treating Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Clostridium Difficile Associated Disease Clinical Trial
Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
M7824 and Eribulin Mesylate in Treating Participants With Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Catheter-Related Infections Clinical Trial
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Catheter-Related Infections Clinical Trial
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Catheter-Related Infections Clinical Trial
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Catheter-Related Infections Clinical Trial
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of ASP1948, Targeting an Immune Modulatory Receptor, in Subjects With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, MuSK Clinical Trial
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, MuSK Clinical Trial
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Rheumatology Clinical Trial
Lipids, Inflammation, and CV Risk in RA
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Resourcefulness Training and Decentering on Self-Management in Caregivers of Technology Dependent Children
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology, Orthopedics / Podiatry, Other Clinical Trial
Study of Aspirin in Patients With Vestibular Schwannoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects With Acute Myeloid Leukemia Who Are 60 Years or Older - The BATTLE Study
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Angiogenic Imaging in Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Orthopedics / Podiatry, Other Clinical Trial
Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Prospective Phenotyping of Autonomous Aldosterone Secretion
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation (REM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Disease Clinical Trial
Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Participants With Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Pharmacology / Toxicology Clinical Trial
Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) Clinical Trial
Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus Clinical Trial
Readmission Prevention Pilot Trial in Diabetes Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Blepharoptosis Clinical Trial
Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Stress Management and Resiliency Training for Physicians
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hypotension and Shock Clinical Trial
Measurement of Hemodynamic Responses to Lower Body Negative Pressure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mild Traumatic Brain Injury Clinical Trial
Enhancing Brain Training With Virtual Reality
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nutritional and Metabolic Diseases Clinical Trial
Microbial Basis of Systemic Malodor and PATM Conditions
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
no Condition Being Studied; tDCS Only in Healthy Subjects Clinical Trial
Using tDCS to Enhance Learning of a New Walking Pattern
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Achondroplasia Clinical Trial
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Achondroplasia Clinical Trial
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Achondroplasia Clinical Trial
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg Daily and 50 mg Daily of REL-1017 in Major Depressive Disorder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg Daily and 50 mg Daily of REL-1017 in Major Depressive Disorder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Child Development Clinical Trial
Growth and Tolerance of Infants Fed Formula for 16 Weeks
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Child Development Clinical Trial
Growth and Tolerance of Infants Fed Formula for 16 Weeks
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Child Development Clinical Trial
Growth and Tolerance of Infants Fed Formula for 16 Weeks
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
Updated: 12/31/1969
PSD502 in Subjects With Premature Ejaculation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
Updated: 12/31/1969
PSD502 in Subjects With Premature Ejaculation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Adavosertib With or Without Olaparib in Treating Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Clostridium Difficile Associated Disease Clinical Trial
Updated: 12/31/1969
Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
M7824 and Eribulin Mesylate in Treating Participants With Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Catheter-Related Infections Clinical Trial
Updated: 12/31/1969
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Catheter-Related Infections Clinical Trial
Updated: 12/31/1969
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Catheter-Related Infections Clinical Trial
Updated: 12/31/1969
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Catheter-Related Infections Clinical Trial
Updated: 12/31/1969
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Updated: 12/31/1969
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Updated: 12/31/1969
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Updated: 12/31/1969
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Updated: 12/31/1969
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Updated: 12/31/1969
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Updated: 12/31/1969
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of ASP1948, Targeting an Immune Modulatory Receptor, in Subjects With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Updated: 12/31/1969
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, MuSK Clinical Trial
Updated: 12/31/1969
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, MuSK Clinical Trial
Updated: 12/31/1969
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Rheumatology Clinical Trial
Updated: 12/31/1969
Lipids, Inflammation, and CV Risk in RA
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Updated: 12/31/1969
Resourcefulness Training and Decentering on Self-Management in Caregivers of Technology Dependent Children
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology, Orthopedics / Podiatry, Other Clinical Trial
Updated: 12/31/1969
Study of Aspirin in Patients With Vestibular Schwannoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects With Acute Myeloid Leukemia Who Are 60 Years or Older - The BATTLE Study
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Angiogenic Imaging in Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Orthopedics / Podiatry, Other Clinical Trial
Updated: 12/31/1969
Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Prospective Phenotyping of Autonomous Aldosterone Secretion
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation (REM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
Updated: 12/31/1969
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Disease Clinical Trial
Updated: 12/31/1969
Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Participants With Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Pharmacology / Toxicology Clinical Trial
Updated: 12/31/1969
Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) Clinical Trial
Updated: 12/31/1969
Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Readmission Prevention Pilot Trial in Diabetes Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Blepharoptosis Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Updated: 12/31/1969
Stress Management and Resiliency Training for Physicians
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hypotension and Shock Clinical Trial
Updated: 12/31/1969
Measurement of Hemodynamic Responses to Lower Body Negative Pressure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mild Traumatic Brain Injury Clinical Trial
Updated: 12/31/1969
Enhancing Brain Training With Virtual Reality
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nutritional and Metabolic Diseases Clinical Trial
Updated: 12/31/1969
Microbial Basis of Systemic Malodor and PATM Conditions
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
no Condition Being Studied; tDCS Only in Healthy Subjects Clinical Trial
Updated: 12/31/1969
Using tDCS to Enhance Learning of a New Walking Pattern
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
Updated: 12/31/1969
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Achondroplasia Clinical Trial
Updated: 12/31/1969
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Achondroplasia Clinical Trial
Updated: 12/31/1969
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Achondroplasia Clinical Trial
Updated: 12/31/1969
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg Daily and 50 mg Daily of REL-1017 in Major Depressive Disorder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg Daily and 50 mg Daily of REL-1017 in Major Depressive Disorder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Child Development Clinical Trial
Updated: 12/31/1969
Growth and Tolerance of Infants Fed Formula for 16 Weeks
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Child Development Clinical Trial
Updated: 12/31/1969
Growth and Tolerance of Infants Fed Formula for 16 Weeks
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Child Development Clinical Trial
Updated: 12/31/1969
Growth and Tolerance of Infants Fed Formula for 16 Weeks
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials